Cannabis for mental health in the workplace

Cannabis has been a legal psychoactive substance in Canada since 2018. Since then we have seen reforms in progress. So advanced that some jobs now allow cannabis use during office hours.

Seeing cannabis and the workplace in the same sentence may seem strange. However, it is the truth. Not all cannabis strains keep the consumer locked on the couch. Some induce a productive streak in the worker. It is commendable that some workplaces have chosen to take advantage of this fact.

Some companies may soon allow a pot to be consumed during office hours. However, this is only possible if it has been demonstrated that the strain has very little effect on reducing productivity.

It could be a challenge for small and large companies on an international scale. But there is still a long way to go before all of this can happen.

Other companies would still have the right to zero tolerance to the drug room, but they would not have the right to claim that a worker shouldn’t get a stone in his spare time.

There will come a time when cannabis use will be equated with alcohol use in social settings. By then, Canada will have a very balanced system in which all workplaces can have policies on workplace safety and other liability issues.

Some of these guidelines may be, “Don’t smoke on duty, don’t get stoned at work, smoke anything you want when you are away from work, etc.”

In the workplace, cannabis prohibitions are far more obscure than alcohol. While excessive consumption of either can limit a worker’s performance.

Some organizations have begun to actively participate in the cannabis prosecution in Canada. These organizations are in because they believe cannabis has the potential to improve the mental health and productivity of workers in the various companies in Canada.

This article is limited to the three main organizations involved. You are;

CMHC is a facility charged with studying the relationship between Canada’s mental health and cannabis use. They also examine existing works and examine the links between cannabis use and mental health.

Through their research, they have found, in part, that cannabis improves the mental health of Canadians in their workplace. They lead the task of studying certain types of cannabinoid use to determine how they can affect productivity in the workplace. The intensive research is still ongoing and the existing cannabis reforms in the country make the process really smooth.

CMHC believes the decriminalization of cannabis in Canada will enable the country to become a leading force in cannabis and mental health research.

Based on their findings, the Canadian Mental Health Commission (CMHC) has estimated the economic burden of mental health problems in the workplace at a staggering $ 52 billion a year. 40% of this amount is associated with a loss of productivity. It’s not uncommon for chronic pain to be one of the likely effects of mental health problems.

That is, there is a relationship between mental and physical health. Poor mental health can manifest itself as a mood disorder or other form of physical pain.

It is worth recalling that in 2017, CHMC conducted a survey of Canadian tobacco, drug and alcohol use. They reported that over 37% of marijuana users use drugs for medical purposes.

Several companies argue that all forms of cannabis use affect a worker’s ability to work efficiently in the workplace. They believe that marijuana decreases the person’s productivity in the workplace. Some have lingering prejudices that make them doubt whether their employees actually make use of it for medical reasons.

These organizations are partners in raising awareness of the benefits of cannabis. They are educational communities, corporations, employees, and employers who participate in cannabis programs that can help Canadian businesses be more productive, and thereby increase their revenues.

CCDRC is a national body that develops cannabis educational materials for home and internal use. These materials are designed to improve the various industries as well as industry associations.

CannaQuest is a pharmaceutical company that infuses cannabinoid compounds and other botanical molecules. The company focuses on the development of cannabis drugs that can be used to treat mental disorders such as depression, addiction, schizophrenia, post-traumatic stress disorder, and anxiety.

The partnership between CannaQuest and CCDRC is backed by science-based evidence and published data from the renowned Dr. Steven Laviolette and his team in Canada work together. Dr. Laviolette is the man for the job because he and his team studied the effects of CBD on mental health and overall wellbeing.

Thanks to extensive research by CannaQuest Medical Corp, many wellness drugs and nutraceuticals have been made available to the population of Canada. These products have little to very little intoxicating effects. They have been tested in the diverse Canadian population.

Because of this, they are ready to lead the mental health cannabis prosecution in Canadian workplaces.

Changes cannot be avoided, who would have thought that the whole world would have already adapted to the COVID-19 pandemic. Canadian companies need to embrace change and take steps that create a safe working environment for their employees.

With the involvement of these three organizations, companies can be better equipped with cannabis solution guidelines that address workers who need the drug for improved mental health.

I will end with a comment from Treena Reilkoff, a moderator and trauma-informed mediator at CCDRC, explaining the goals of these organizations.

Our common goal is to recognize that medical cannabis is an alternative treatment to traditional medicines, and by educating people about the practicality and safety of medical cannabis, barriers and scars will be reduced. “

Hopefully everything will be fine as time goes by.







Post a comment:

Your email address will not be published. Required fields are marked *